The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens.
Open accessAbstract
The purpose of this study was to determine whether bone density in older men was associated with serum sex steroids or sex hormone binding globulin (SHBG). Bone density and sex steroids were measured in men over age 65 at 6-mo intervals for an average of 2.1 yr. Bone density was significantly positively associated with greater serum E2 concentrations (+0.21 < r < +0.35; 0.01 < P < 0.05) at all skeletal sites. There were weak negative correlations between serum testosterone and bone density (-0.20 < r < -0.28; 0.03 < P < 0.10) at the spine and hip. SHBG was negatively associated only with bone density in the greater trochanter (r = -0.26, P < 0.05). Greater body weight was associated with lower serum testosterone and SHBG, and greater E2. Because of these associations, regression models which adjusted for age, body weight, and serum sex steroids were constructed; these accounted for 10-30% of the variability in bone density, and showed consistent, significant positive associations between bone density and serum E2 concentrations in men, even after adjustments for weight and SHBG. These data suggest that estrogens may play an important role in the development or maintenance of the male skeleton, much as is the case for the female skeleton. These data also indicate that, within the normal range, lower serum testosterone concentrations are not associated with low bone density in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in men, bone mineral density (BMD) at the greater trochanter, femoral neck and the lumbar spine is negatively correlated with concentrations of SHBG [146, 150–152].”
From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [151]
Experimental — accuracy not yet measuredIn the citing paper
“These confounding results leave uncertainty in the relationship between T levels in aging and bone health.”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Cooper, C. C., Atkinson, E. J., MichaelO'Fallon, W., & Melton, J. L. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070214 · Cited by 1,526
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Khosla, S., Amin, S., & ORWOLL, E. S. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 943
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L., Hart, D., Macdonald, E., & Clarke, A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 875
Estrogen Replacement Therapy and Fractures in Older Women
Cauley, J. A., Seeley, D. G., Ensrud, K. E., Ettinger, B., Black, D., & Cummings, S. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00002 · Cited by 808
Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791 · cited 2×
“Men with spinal crush fractures have also been shown to have significantly higher serum concentrations of markers of skeletal remodeling (osteocalcin) (22), and it is possible that this mechanism, which is clearly central to the development of low bone mass in women, is also involved in the development of low bone mas…”
BackgroundGenetic Factors in Determining Bone Mass
Smith, D. M., Nance, W. E., Kang, K.-W., Christian, J. C., & Johnston, C. C. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107476 · Cited by 579
Self-citationPrediction of osteoporotic fractures by postural instability and bone density.
Nguyen, T. V., Sambrook, P. N., Kelly, P. J., Jones, G., Lord, S. R., Freund, J., & Eisman, J. A. (1993) · BMJ · doi:10.1136/bmj.307.6912.1111 · Cited by 568
ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE CELLS IN VITRO
Kasperk, C. H., Wergedal, J. E., Farley, J. R., Linkhart, T. A., Turner, R. T., & Baylink (1989) · Endocrinology · doi:10.1210/endo-124-3-1576 · Cited by 398
Cited by
Sorted by citations
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
“Several groups have reported substantial decreases in serum levels of free or Bio sex steroid levels with aging (17, 160, 161).”
BackgroundMethodRiggs, B. L., Khosla, S., & Melton, L. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.763 · Cited by 1,161
Khosla, S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2266 · Cited by 447
“(21) found that serum estradiol (E2), but not T, levels were positively associated with BMD in men over age 65 yr.”
InfluentialKhosla, S., Amin, S., & ORWOLL, E. S. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 943
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 622
van den Beld, A. W., de Jong, F. H., Grobbee, D. E., Pols, H. A. P., & Lamberts, S. W. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6825 · Cited by 618
“Recently it has been demonstrated that estrogens play an important role in maintaining BMD in healthy older men (5, 30 ).”
BackgroundAging and bone loss: new insights for the clinician
Demontiero, O., Vidal, C., & Duque, G. (2011) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11430858 · Cited by 602
“A combination of crosssectional and observational studies of aging men showed better correlations between serum estradiol and BMD than testosterone and BMD at various skeletal sites [Slemenda et al. 1997; Khosla et al. 2001, 2008b; Mellstrom et al. 2008; Szulc et al. 2001].”
BackgroundRiggs, B. L., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., McDaniel, L. J., Amin, S., Rouleau, P. A., & Khosla, S. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071020 · Cited by 543
“For postmenopausal women, there were multiple significant correlations of Bio-E, Bio-T, and FSH, with both cortical and trabecular bone loss at all scanning sites.”
BackgroundAndropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
“In recent studies, a stronger correlation is found between bioavailable E2 levels and BMD and fracture risk than between T and these outcomes, suggesting that the age-related reduction in bioavailable E2 levels may be a more important determinant of bone loss with aging in men than T levels (139,140,306,308,311, 318,3…”
BackgroundKenny, A. M., Prestwood, K. M., Gruman, C. A., Marcello, K. M., & Raisz, L. G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.m266 · Cited by 456
The Estrogen Receptor β Subtype: A Novel Mediator of Estrogen Action in Neuroendocrine Systems
Kuiper, G. G. J. M., Shughrue, P. J., Merchenthaler, I. J., & Gustafsson, J.-Α. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0170 · Cited by 438
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action
Grumbach, M. M., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6290 · Cited by 412
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice
Vidal, O., Lindberg, M. K., Hollberg, K., Baylink, D. J., Andersson, G., Lubahn, D. B., Mohan, S., Gustafsson, J.-Α., & Ohlsson, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5474 · Cited by 388
Eisman, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0384 · Cited by 380
Pathophysiology of Age-Related Bone Loss and Osteoporosis
Khosla, S., & Riggs, B. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.009 · Cited by 376
“Slemenda and colleagues [54] found that BMD at various sites in 93 healthy men over age 55 years correlated with serum estradiol levels (correlation coefficients, depending on the site, of þ0.”
BackgroundPlasma steroid-binding proteins: primary gatekeepers of steroid hormone action
Hammond, G. L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0070 · Cited by 356
“…changes in the plasma levels and distribution of sex steroids, are not only predictive of numerous clinical conditions, including low bone density (Slemenda et al. 1997) and osteoporotic fracture (Cawthon et al. 2016) in men, and risk for the metabolic syndrome and its associated diseases in both…”
Khosla, S., Melton, L. J., & Riggs, B. L. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.262 · Cited by 344
Mellström, D., Johnell, O., Ljunggren, Ö., Eriksson, A.-L., Lorentzon, M., Mallmin, H., Holmberg, A., Redlund-Johnell, I., Orwoll, E., & Ohlsson, C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060110 · Cited by 337
Estrogen and the Male Skeleton
Khosla, S., Melton, L. J., & Riggs, B. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8417 · Cited by 308
Amin, S., Zhang, Y., Sawin, C. T., Evans, S. R., Hannan, M. T., Kiel, D. P., Wilson, P. W. F., & Felson, D. T. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00010 · Cited by 291
“Of note, a similar association was also seen in another study (27), in which sex hormone–binding globulin was measured.”
ResultThe Pathophysiology and Treatment of Osteoporosis
Drake, M. T., Clarke, B. L., & Lewiecki, E. M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.006 · Cited by 292
Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283
Osteoporosis, genetics and hormones
Rizzoli, R., Bonjour, J., & Ferrari, S. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260079 · Cited by 280
“They control bone remodeling during reproductive life in females (Rizzoli & Bonjour 1997, Riggs et al. 1998) and later on in aging men (Slemenda et al. 1996b, 1997, Greendale et al. 1997).”
BackgroundArmstrong, V. J., Muzylak, M., Sunters, A., Zaman, G., Saxon, L., Price, J. S., & Lanyon, L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703224200 · Cited by 276
Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Mellström, D., Vandenput, L., Mallmin, H., Holmberg, A. H., Lorentzon, M., Odén, A., Johansson, H., Orwoll, E. S., Labrie, F., Karlsson, M. K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080518 · Cited by 279
Bioavailable Estradiol May Be an Important Determinant of Osteoporosis in Men: The MINOS Study
Szulc, P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.192 · Cited by 169
Clarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
“[65], found correlation coefficients between serum total estradiol and BMD at different skeletal sites ranging from +0.”
BackgroundSmith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
Biological Role of Estrogen and Estrogen Receptors
Nilsson, S. V., & Gustafsson, J.-Å. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771438 · Cited by 246
LeBlanc, E. S., Nielson, C. M., Marshall, L. M., Lapidus, J. A., Barrett-Connor, E., Ensrud, K. E., Hoffman, A. R., Laughlin, G., Ohlsson, C., Orwoll, E. S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0206 · Cited by 240
Osteoprotegerin Serum Levels in Men: Correlation with Age, Estrogen, and Testosterone Status
Szulc, P., Hofbauer, L. C., Heufelder, A. E., Roth, S., & Delmas, P. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7657 · Cited by 250
Meier, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.2 · Cited by 274
“The median (range) serum testosterone level for quartile 1 was 227 (3-291) ng/dL; for quartile 2, 343 (294-398) ng/dL; for quartile 3, 473 (401-559) ng/dL; and for quartile 4, 646 (559-1519) ng/dL.”
BackgroundPathogenesis of Age-Related Bone Loss in Humans
Khosla, S. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls163 · Cited by 222
“However, Slemenda and colleagues (43) found that BMD (assessed by DXA) at various sites in 93 healthy men more than age 55 years correlated with serum estradiol levels (correlation coefficients, depending on the site, of +0.”
BackgroundFerretti, J. L., Capozza, R. F., Cointry, G. R., García, S. L. O., Plotkin, H., Filgueira, M. L. A., & Zanchetta, J. (1998) · Bone · doi:10.1016/s8756-3282(98)00046-5 · Cited by 220
Osteoporosis and Periodontitis
Wang, C., & McCauley, L. K. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0330-3 · Cited by 218
Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications
Pataky, M. W., Young, W. F., & Nair, K. S. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.033 · Cited by 207
Bone Aging, Cellular Senescence, and Osteoporosis
Pignolo, R. J., Law, S. F., & Chandra, A. (2021) · JBMR Plus · doi:10.1002/jbm4.10488 · Cited by 217
“Current understanding indicates that estrogen may play a role in the bone health of both postmenopausal women((196)) and aging men.((197,198)) Although the role of testosterone in regulating BMD in men was not consistent between studies,((197,198)) some studies found a direct correlation with declining testosterone le…”
ResultOh, K. W., Lee, W., Rhee, E., Baek, K. H., Yoon, K., Kang, M. I., Yun, E. J., Park, C., Ihm, S. H., Choi, M. G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02312.x · Cited by 200
Bone Has a Sexually Dimorphic Response to Aromatase Deficiency
Öz, O. K., Zerwekh, J. E., Fisher, C., Graves, K. H., Nanu, L., Millsaps, R., & Simpson, E. R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.507 · Cited by 194
Longitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men
Gennari, L., Merlotti, D., Martini, G., Gonnelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030736 · Cited by 235
“(12) examined the role of sex steroids on bone mass in a group of elderly men followed longitudinally for an average of 2.”
InfluentialEstradiol, Testosterone, and the Risk for Hip Fractures in Elderly Men from the Framingham Study
Amin, S., Zhang, Y., Felson, D. T., Sawin, C. T., Hannan, M. T., Wilson, P. W. F., & Kiel, D. P. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.048 · Cited by 191
Aromatase Activity and Bone Homeostasis in Men
Gennari, L., Nuti, R., & Bilezikian, J. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1717 · Cited by 191
Khosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191
“• Sex Steroids and Osteoprotegerin J Clin Endocrinol Metab, April 2002, 87(4):1550–1554 1553”
BackgroundInfluentialCancer Treatment–Induced Bone Loss in Breast and Prostate Cancer
Fred Saad, C., Adachi, J. D., Brown, J. P., Canning, L. A., Gelmon, K. A., Josse, R. G., & Pritchard, K. I. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.4184 · Cited by 182
Androgen deprivation therapy for prostate cancer results in significant loss of bone density
Wei, J., Gross, M. D., Jaffe, C. A., Gravlin, K., Lahaie, M., Faerber, G. J., & Cooney, K. A. (1999) · Urology · doi:10.1016/s0090-4295(99)00301-5 · Cited by 170
Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study
Meier, C., Nguyen, T. V., Seibel, M. J., & Eisman, J. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041207 · Cited by 169
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
Olszynski, W. P., Davison, K. S., Adachi, J. D., Brown, J. P., Cummings, S. R., Hanley, D. A., Harris, S. P., Hodsman, A. B., Kendler, D. L., McClung, M. R., et al. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90002-1 · Cited by 166
Osteoporosis in Men Treated With Androgen Deprivation Therapy for Prostate Cancer
Ross, R. W., & Small, E. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65060-4 · Cited by 166
Khosla, S., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Oberg, A. L., Rouleau, P. A., & Riggs, B. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041228 · Cited by 161
Lorentzon, M., Swanson, C., Andersson, N., Mellström, D., & Ohlsson, C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050404 · Cited by 162
Gennari, L., Masi, L., Merlotti, D., Picariello, L., Falchetti, A., Tanini, A., Mavilia, C., Monte, F. D., Gonnelli, S., Lucani, B., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031342 · Cited by 158
Androgen deprivation therapy for prostate cancer: new concepts and concerns
Smith, M. R. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32814db88c · Cited by 157
Lee, H., McGovern, K., Finkelstein, J. S., & Smith, M. R. (2005) · Cancer · doi:10.1002/cncr.21381 · Cited by 148
Burnett-Bowie, S.-A. M., McKay, E. A., Lee, H., & Leder, B. Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0739 · Cited by 146
Goderie-Plomp, H. W., van der Klift, M., de Ronde, W., Albert Hofman, D., de Jong, F. H., & Pols, H. A. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022041 · Cited by 146
Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton
Gaddini, G. W., Turner, R. T., Grant, K. A., & Iwaniec, U. T. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13000 · Cited by 141
“Lower serum estrogen is associated with lower BMD in elderly men and women (Slemenda et al., 1997; Wosje and Kalkwarf, 2007), and estrogen replacement therapy slows bone loss (Felson et al., 1993) and decreases fracture risk (Cauley et al., 1995).”
Osteoporosis in Men Treated With Androgen Deprivation Therapy for Prostate Cancer
Ross, R. W., & Small, E. J. (2002) · The Journal of Urology · doi:10.1097/00005392-200205000-00003 · Cited by 142
Determinants of Peak Bone Mass and Mechanisms of Bone Loss
Rizzoli, R., & Bonjour, J. ‐. (1999) · Osteoporosis International · doi:10.1007/pl00004155 · Cited by 141
“Female sex hormones appear to be mandatory not only for the acquisition of the maximal mass of bone in both males and females [52–54], but also for the maintenance of this mass by controlling bone remodeling during reproductive life in female [55,56] and in aging men [57,58].”
BackgroundTumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Smyrk, T. C., Watson, P. A., Kaul, K. L., & Lynch, H. T. (2001) · Cancer · doi:10.1002/1097-0142(20010615)91:12 · Cited by 522
Mueller, A., Haeberle, L., Zollver, H., Claassen, T., Kronawitter, D., Oppelt, P. G., Cupisti, S., Beckmann, M. W., & Dittrich, R. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01912.x · Cited by 135
Movérare, S., Venken, K., Eriksson, A.-L., Andersson, N., Skrtic, S., Wergedal, J. E., Mohan, S., Salmon, P., Bouillon, R., Gustafsson, J.-Α., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233084100 · Cited by 131
Estrogens as regulators of bone health in men
Vandenput, L., & Ohlsson, C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.112 · Cited by 133
Amin, S., & Felson, D. T. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70186-1 · Cited by 123
Coin, A., Perissinotto, E., Enzi, G., Zamboni, M. M., İnelmen, E., Frigo, A. C., Manzato, E., Busetto, L., Buja, A., & Sergi, G. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602779 · Cited by 125
“This association has been explained on the strength of biomechanical forces (Glynn et al., 1995) and a greater aromatization of androgens at subcutaneous adipose tissue level (Rebuffe-Scrive et al., 1990; Murphy et al., 1993; Vaananen and Harkonen, 1996; Slemenda et al., 1997).”
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., Price, D., SIEBER, P. R., Barnette, K. G., Rodriguez, D., & Steiner, M. S. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.08.137 · Cited by 117
Doran, P. M., Riggs, B. L., Atkinson, E. J., & Khosla, S. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.11.2118 · Cited by 115
“(10,16,17) Finally, we recently have extended these observations by showing that levels of serum estrogen, but not of serum testosterone, predict rates of bone resorption and bone loss in elderly men (18) and that estrogen is the dominant sex steroid preventing the increase in bone resorption after the induction of hy…”
BackgroundKe, H. Z., Qi, H., Crawford, D. T., Chidsey-Frink, K. L., Simmons, H. A., & Thompson, D. D. (2000) · Endocrinology · doi:10.1210/endo.141.4.7408 · Cited by 116
Dietary Protein Deficiency Induces Osteoporosis in Aged Male Rats
Bourrin, S., Toromanoff, A., Ammann, P., Bonjour, J., & Rizzoli, R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1555 · Cited by 114
Taxel, P., Kennedy, D., FALL, P. M., Willard, A. K., Clive, J. M., & Raisz, L. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7541 · Cited by 117
Determinants of bone density in healthy older men with low testosterone levels
Kenny, A. M., Prestwood, K. M., Marcello, K. M., & Raisz, L. G. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.9.m492 · Cited by 111
“The studies that found estrogen to be more predictive examined younger men with testosterone levels in the normal range (10) or evaluated only total testosterone rather than bioavailable testosterone (13).”
BackgroundEisman, J. A. (1999) · Endocrine Reviews · doi:10.1210/er.20.6.788 · Cited by 111
Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology
Rochira, V., Balestrieri, A., Madeo, B., Zirilli, L., Granata, A. R. M., & Carani, C. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02088 · Cited by 107
Andropause: is androgen replacement therapy indicated for the aging male?
Hijazi, R. A., & Cunningham, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104518 · Cited by 105
Barreto, F. C., Barreto, D. V., Moysés, R. M. A., Neves, C. L., Jorgetti, V., Draibe, S. A., Canziani, M. E. F., & Carvalho, A. B. (2006) · Kidney International · doi:10.1038/sj.ki.5000311 · Cited by 101
Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04562-1 · Cited by 96
Osteoporosis in men: a potential role for the sex hormone binding globulin
Legrand, E., Hedde, C., Gallois, Y., Degasne, I., Boux de Casson, F., Mathieu, E., Baslé, M.-F., Chappard, D., & Audran, M. (2001) · Bone · doi:10.1016/s8756-3282(01)00478-1 · Cited by 127
The effects of testosterone on osteoporosis in men
Francis (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00730.x · Cited by 101
Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms
Gennari, L., Becherini, L., Falchetti, A., Masi, L., Massart, F., & Brandi, M. L. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00043-2 · Cited by 102
Osteoporosis during androgen deprivation therapy for prostate cancer
Smith, M. R. (2002) · Urology · doi:10.1016/s0090-4295(02)01579-0 · Cited by 102
Wong, S. Y. S., Lau, E. M. C., Lynn, H., Leung, P., Woo, J., Cummings, S., & ORWOLL, E. S. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1730-2 · Cited by 98
Gennari, L., & Bilezikian, J. P. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.008 · Cited by 98
Ebeling, P. R. (1998) · Drugs & Aging · doi:10.2165/00002512-199813060-00002 · Cited by 98
“[79] There were also negative associ-”
Pottelbergh, I. V., Lumbroso, S., Goemaere, S., Sultan, C., & Kaufman, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01403.x · Cited by 95
“However, the findings have not been consistent and the reported correlations were weak (Drinka et al., 1993; Greendale et al., 1997; Slemenda et al., 1997; Center et al., 1999).”
Estrogens and Bone Health in Men
Khosla, S., Melton, L. J., & Riggs, B. L. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1044-8 · Cited by 72
“[6] initially reported that in men over age 65 years, BMD was significantly positively associated with serum estradiol levels at all skeletal sites (correlation coefficients of 0.”
BackgroundJärvinen, T. L. N., Kannus, P., Pajamäki, I., Vuohelainen, T., Tuukkanen, J., Järvinen, M., & Sievänen, H. T. (2003) · Bone · doi:10.1016/s8756-3282(03)00100-5 · Cited by 97
“Although estrogen is the predominant female sex hormone, some believe that estrogen actually is the major biologically active bone steroid in males, too [15–17].”
BackgroundAnawalt, B. D., & Merriam, G. R. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70206-1 · Cited by 93
Zaman, G., Saxon, L., Sunters, A., Hilton, H., Underhill, P., Williams, D., Price, J. S., & Lanyon, L. E. (2009) · Bone · doi:10.1016/j.bone.2009.10.021 · Cited by 95
“the subsequent slower, progressive age-related loss that occurs in both men and women are substantially related to their levels of bioavailable estrogen [7–10].”
BackgroundLindberg, M., Erlandsson, M. C., Alatalo, S., Windahl, S. H., Andersson, G. N., Halleen, J., Carlsten, H., Gustafsson, J., & Ohlsson, C. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1710425 · Cited by 91
Gillberg, P., Johansson, A. G., & Ljunghall, S. (1999) · Calcified Tissue International · doi:10.1007/s002239900604 · Cited by 90
“serum estradiol concentrations in a group of healthy men over age 55 [ 26 ].”
BackgroundChristmas, C., O'Connor, K. G., Harman, S. M., Tobin, J. D., Münzer, T., Bellantoni, M. F., Clair, C. S., Pabst, K. M., Sorkin, J. D., & Blackman, M. R. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.1.m12 · Cited by 90
The importance of oestrogens in males
de Ronde, W., Pols, H. A. P., van Leeuwen, J. P. T. M., & de Jong, F. H. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01669.x · Cited by 85
“In most cross-sectional studies the plasma total testosterone concentration, after adjustment for age and weight, is not related to BMD at different sites of the skeleton (Meier et al., 1987; Murphy et al., 1993; Greendale et al., 1997; Slemenda et al., 1997; Amin et al., 2000).”
BackgroundKirchengast, S., Peterson, B., Hauser, G., & Knogler, W. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00205-5 · Cited by 83
ERβ a Novel Estrogen Receptor Offers the Potential for New Drug Development
Nilsson, S. V., Kuiper, G. G. J. M., & Gustafsson, J.-Α. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00096-4 · Cited by 80
Khosla, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3555 · Cited by 522
Pande, I., & Francis, R. M. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0158 · Cited by 80
Ke, H. Z., Qi, H., Chidsey-Frink, K. L., Crawford, D. T., & Thompson, D. D. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.4.765 · Cited by 80
Testosterone Prevents Orchidectomy-Induced Bone Loss in Estrogen Receptor-α Knockout Mice
Vandenput, L., EDERVEEN, A. G. H., Erben, R. G., Stähr, K., Swinnen, J. V., Herck, E. V., Verstuyf, A., Boonen, S., Bouillon, R., & Vanderschueren, D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5101 · Cited by 80
Metadata
- Authors
- Slemenda, C. W., Longcope, C., Zhou, L., Hui, S. L., Peacock, M., & Johnston, C. C.
- Affiliations
- Indiana University Indianapolis (US)
- University of Massachusetts Chan Medical School (US)
- Indiana University School of Medicine (US)
- Indiana University Bloomington (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1997-10-01
- Volume
- 100
- Issue
- 7
- Pages
- 1755-1759
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508359
- OpenAlex
- W1993231839
- Cited by
- 455
- References
- 28
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 6 · 2013: 7 · 2012: 16
- FWCI
- 24.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ag005793-15)
- National Institute on Aging (P01-AG-05793)
- National Center for Research Resources (M01RR000750)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- sex steroids, bone mineral density, older men, serum estrogen, estradiol, testosterone, sex hormone-binding globulin, bone mass, body weight, male skeleton
- MeSH terms
- Aged, Androgens, Body Constitution, Dehydroepiandrosterone, Estradiol, Estrogens, Estrone, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Regression Analysis, Sex Hormone-Binding Globulin, Testosterone, Models, Statistical, Bone Density, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review